CMS “Retail” Insurance Model: How Prescription Drugs Fit In
This article was originally published in RPM Report
Executive Summary
The ACA exchange rules regarding formularies aren’t written the way most in the biopharma industry would like. But that is likely to change over time, assuming CMS’ vision of a “retail” health insurance market is correct.